Live Breaking News & Updates on Lupin limited

Stay informed with the latest breaking news from Lupin limited on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Lupin limited and stay connected to the pulse of your community

9th Edition of the India Health and Wellness Awards 2024 Celebrate Excellence in Healthcare, Innovations in Health and Patient Centric Approach Recognised

Mumbai: A glittering celebration of excellence in healthcare was witnessed with illustrious gathering of industry stalwarts, policymakers, and healthcare luminaries, at the 9th edition of IHW Awards, an event conceived to honour outstanding contribut

Mumbai , Maharashtra , India , Sudarshan-jain , Neelam-diwakar-gorhe , Kamal-narayan , Maharashtra-legislative-council , Sustainable-development-goals , Mental-health-wellbeing-partner , Cipla , Indian-pharmaceutical-alliance , Public-health-foundation-of-india

Lupin : April 25, 2024 Lupin Receives Approval from U.S. FDA for Loteprednol Etabonate Ophthalmic Suspension, 0.5%

Mumbai, Naples, April 25, 2024: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration for its...

United-states , South-africa , India , Mumbai , Maharashtra , Heena-dhedhi , Asia-pacific , Bausch-lomb-inc , Linkedin , Lupin-limited , Corporate-communications , Drug-administration

Lupin : April 25, 2024 Lupin Digital Health's Lyfe Platform Receives Class C Medical Device License from CDSCO

First chronic condition management platform to be recognized as a Class C 'Software as a Medical Device'

Mumbai, April 25, 2024: Lupin Digital Health, India's...

Mumbai , Maharashtra , India , South-africa , Asia-pacific , Sidharth-srinivasan , Rajeev-sibal , Central-drugs-standard-control-organization , Facebook , Biotechnology-pharmaceuticals , Classc-software , Twitter

Lupin : April 23, 2024 Lupin Receives EIR from U.S. FDA for its Aurangabad Manufacturing Facility

Mumbai, Naples, April 23, 2024: Global pharma major Lupin Limited today announced that it has received the Establishment Inspection Report from the United States Food and Drug...

Mumbai , Maharashtra , India , South-africa , United-states , Aurangabad , Asia-pacific , Nilesh-gupta , Biotechnology-pharmaceuticals , Facebook , Lupin-limited , Linkedin

Lupin's Aurangabad facility gets zero adverse observations in US FDA's latest inspection

The inspection took place from March 6 to March 15, 2024, and the U.S. FDA classified the facility as Voluntary Action Indicated (VAI).

United-states , Aurangabad , Maharashtra , India , Nilesh-gupta , Drug-administration , Lupin-limited , Establishment-inspection-report , United-states-food , Voluntary-action-indicated , Managing-director ,

Lupin Launches New Generic Drug In US Market - IndiaWest Journal News

Lupin Launches New Generic Drug In US Market - IndiaWest Journal News
indiawest.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiawest.com Daily Mail and Mail on Sunday newspapers.

South-africa , India , Mumbai , Maharashtra , United-states , America , Asia-pacific , Drug-administration , Astellas-pharma-global-development-inc , Lupin-limited , Extended-release-tablets , Astellas-pharma-global-development

Lupin receives Establishment Inspection Report from USFDA for its Aurangabad manufacturing facility

The inspection was conductedfrom March 6 to March 15, 2024. The U.S. FDA has determined that the inspection classification ofthe facility is Voluntary Action Indicated (VAI)

Aurangabad , Maharashtra , India , United-states , Nilesh-gupta , Drug-administration , Board-of-directors-the-company , Lupin-limited-on , Voluntary-action-indicated , Lupin-limited , Establishment-inspection-report , United-states-food

Lupin : April 22, 2024 Lupin Launches Mirabegron Extended-Release Tablets in the United States

Mumbai, Naples, April 20, 2024: Global pharma major Lupin Limited today announced the launch of Mirabegron Extended-Release Tablets, 25 mg, in the United States, after having received...

South-africa , India , Mumbai , Maharashtra , United-states , Asia-pacific , Heena-dhedhi , Linkedin , Biotechnology-pharmaceuticals , Lupin-limited , Astellas-pharma-global-development-inc , Corporate-communications

Lupin Launches New Generic Drug In US Market

Lupin Launches New Generic Drug In US Market
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

India , United-states , Mumbai , Maharashtra , South-africa , Asia-pacific , Astellas-pharma-global-development-inc , Drug-administration , Lupin-limited , United-states-food , Extended-release-tablets , Astellas-pharma-global-development

Lupin launches new generic drug in US market

Pharma major Lupin Limited announced on Monday that it has launched Mirabegron extended-release tablets, 25 mg, in the United States market, after having received approval from the United States Food and Drug Administration (U.S. ...

South-africa , United-states , Mumbai , Maharashtra , India , Asia-pacific , Astellas-pharma-global-development-inc , Drug-administration , Lupin-limited , United-states-food , Extended-release-tablets , Astellas-pharma-global-development